The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

Featured videos videos

The National Amyloidosis Centre: A guide for clinicians

This short video outlines the role of the NAC (National Amyloidosis Centre) in managing patients you refer to them with suspected amyloidosis. It highlighting the use of accurate diagnostic testing techniques available at the NAC, including imaging, histology and proteomics, as well as the genetic testing and counselling that provide important components of holistic care.

Funding for these videos has come from multiple pharmaceutical industry sponsors. Further details of each company’s involvement can be found on the video page.

Exploring cardiac amyloidosis

Exploring cardiac amyloidosis: Diagnosis, treatment, and best practices

Sponsored

Studies report up to 18% (n/N = 9/49) of patients aged ≥60 years old with heart failure with preserved ejection fraction (HFpEF) had transthyretin amyloid cardiomyopathy (ATTR-CM), one of the main types of cardiac amyloidosis.1 Clinical expert Dr Kate Gatenby highlights this and gives an overview of the causes, diagnosis and best practices in the management of patients with ATTR-CM.

Promotional video developed and funded by Pfizer Ltd intended for UK HCPs only.

PP-VYN-GBR-2016 | March 2026

Can artificial intelligence (AI) save UK primary care? An introduction into how digital healthcare may revolutionise and improve general practice.

GPs Neil Paul and Martin Godfrey discuss the functions and roles of artificial intelligence (AI) and how digital healthcare may revolutionise and improve future general practice. In this fascinating and hugely relevant conversation, the doctors explore how AI can support clinicians in contemporary primary care for cardiovascular health.

Cardio-oncology in practice: bridging hospital & community – top tips for generalists

The increasing toxicity profile of cancer treatments has resulted in a growing demand for specialist cardio-oncology care. Listen to Dr SivaTharshini Ramalingam discuss how hospitals and community practitioners can work together to identify, treat and improve the quality of life for people experiencing cardiac dysfunction as a consequence of cancer treatments. She also explains which drugs are most commonly used, their key toxicities and reg flags for care.
Amyloidosis overview – prevalence, pathophysiology and treatment approaches

Amyloidosis overview – prevalence, pathophysiology and treatment approaches

This Masterclass was developed in collaboration with the National Amyloidosis Centre, London UK

Amyloidosis is rapidly gaining recognition as a previously under-diagnosed cause of cardiomyopathy and heart failure. Here, experts from the National Amyloidosis Centre – the only centre in the UK specialising in the management of the condition – provide an overview of its prevalence, symptoms and key treatment principles.

Digital transformations in cardiovascular medicine – where do we begin?

Dr Sarah Hudson and Charles Lowe discuss the latest advancements in digital innovation both supporting and challenging cardiology clinicians in the UK. Topol Fellow, Dr Hudson shares her wealth of knowledge and experience as a cardiologist with Charles Lowe, who’s worked in the digital healthcare space for over 25 years. In this fascinating conversation, we discover what is happening in cardiology clinics and what the future might hold for cardiologists. Look out for future videos covering these topics in more detail:
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.